IABP therapy is deeply rooted in clinical practice, saving tens of thousands of lives throughout the world each year. IABP counterpulsation therapy is used for patients undergoing interventional cardiology procedures, cardiopulmonary bypass, and for patients in acute heart failure and cardiogenic shock. gives us a broader focus on potential opportunities for growth in the large Japanese market." The USCI sales organization will build upon the strong foundation that Datascope's IABP business enjoys in the Japanese market. On behalf of Datascope, I wish to thank Edwards Lifesciences and their staff for helping to grow our IABP business in Japan. Nino Laudani, Datascope's Vice-President and Chief Operating Officer, said "Edwards Lifesciences has been an excellent business partner to Datascope in Japan for many years, dedicated to high standards of business practice. The Datascope Cardiac Assist product line fits perfectly with our strategic focus, and will help us service our two most important stakeholders, cardiac care physicians and their patients." Our holding group is quite strong in interventional cardiology, cardiac rhythm disease management and cardiac surgery. Van Zandt, President and CEO of USCI Japan and COO of USCI Holdings commented, "This is a major step towards achieving our vision of becoming a global company for the global vasculature. USCI will give Datascope comprehensive sales coverage throughout Japan. USCI Holdings Ltd., one of the premier medical device distribution organizations in Japan, will be responsible for sales distribution throughout Japan. will be responsible for import, product service, sales support, and product surveillance of the IABP business. Datascope Japan K.K., a wholly-owned subsidiary of Datascope Corp., was formed to expand Datascope's overall business in Japan.ĭatascope Japan K.K. will manage Datascope's Intra-Aortic Balloon Pump (IABP) business in Japan when Edwards Lifesciences Ltd., the current distributor, exits that business in Japan at the end of the calendar year, as part of that company's continued efforts to focus on its critical care business. (NASDAQ: DSCP) announced today that Datascope Japan K.K. Montvale, N.J., October 22, 2007.Datascope Corp. Datascope to Transfer Its Cardiac Assist Business in Japan to Datascope Japan K.K.
0 kommentar(er)
